Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Hepatobiliary/Pancreas

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Clinical Gastroenterology and Hepatology | Feb 15, 2022 Hepatobiliary/Pancreas

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

The Lancet: Gastroenterology & Hepatology | Feb 12, 2022 Hepatobiliary/Pancreas

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

The Lancet: Gastroenterology & Hepatology | Feb 12, 2022 Hepatobiliary/Pancreas

High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy

Cancer Medicine | Feb 12, 2022 Hepatobiliary/Pancreas

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

Alimentary Pharmacology and Therapeutics | Feb 11, 2022 Hepatobiliary/Pancreas

Pancreatic cancer-associated diabetes mellitus is characterized by reduced β-cell secretory capacity, rather than insulin resistance

Diabetes Research and Clinical Practice | Feb 11, 2022 Hepatobiliary/Pancreas

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Gut | Feb 10, 2022 Hepatobiliary/Pancreas

Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018

Hepatology | Feb 09, 2022 Hepatobiliary/Pancreas

Sustained weight loss, weight cycling, and weight gain during adulthood and pancreatic cancer incidence in the Women’s Health Initiative (US)

American Journal of Epidemiology | Feb 03, 2022 Hepatobiliary/Pancreas

Frequent promoter hypermethylation and down regulation of BNIP3: An early event during gallbladder cancer progression

Digestive and Liver Diseases | Jan 29, 2022 Hepatobiliary/Pancreas

« Prev 1 2 3 4 5 … 118 Next »

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

Pancreatic cancer-associated diabetes mellitus is characterized by reduced β-cell secretory capacity, rather than insulin resistance

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018

Sustained weight loss, weight cycling, and weight gain during adulthood and pancreatic cancer incidence in the Women’s Health Initiative (US)

Frequent promoter hypermethylation and down regulation of BNIP3: An early event during gallbladder cancer progression

Gut Health Disorders and its Management

Autoimmune Disorders and its Management

Effect of Hypertension on eyes : MCQ Challenge

Forensic Medicine and Toxicology: An Introduction

MIP: HIV and Pulmonary System: HIV And Non Infectious Pulmonary Diseases: Dr Bhimasena Rao R S

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy

Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate vs entecavir in the United States

Pancreatic cancer-associated diabetes mellitus is characterized by reduced β-cell secretory capacity, rather than insulin resistance

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018

Sustained weight loss, weight cycling, and weight gain during adulthood and pancreatic cancer incidence in the Women’s Health Initiative (US)

Frequent promoter hypermethylation and down regulation of BNIP3: An early event during gallbladder cancer progression

Gut Health Disorders and its Management

Autoimmune Disorders and its Management

Effect of Hypertension on eyes : MCQ Challenge

Forensic Medicine and Toxicology: An Introduction

MIP: HIV and Pulmonary System: HIV And Non Infectious Pulmonary Diseases: Dr Bhimasena Rao R S

Select Specialty

Select Topic